BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
CYP51
,
Fatty acid metabolic process
,
Hepatitis
,
Adipose tissue
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
serum amyloid protein
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of Bariatric Surgery on Serum Amyloid A Protein: a Systematic Review and Meta-analysis.
A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis.
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.
Serum level of serum amyloid A1 protein in patients with acne vulgaris.
Research status of serum amyloid A in infection: a bibliometric analysis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Serum Amyloid A Protein And Fetuin A Levels
Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ